Emergent BioSolutions Inc (NYSE:EBS)
$ 10.69 -0.2 (-1.84%) Market Cap: 579.23 Mil Enterprise Value: 1.38 Bil PE Ratio: 0 PB Ratio: 1.46 GF Score: 63/100

Q3 2023 Emergent BioSolutions Inc Earnings Call Transcript

Nov 08, 2023 / 10:00PM GMT
Release Date Price: $2.21 (-6.36%)
Operator

Good afternoon, everyone. I'm the operator for today's call. Thank you for joining today as Emergent discusses their operational and financial results for the third quarter of 2023. As it's customary, today's call is open to all participants and the call is being recorded and is copyrighted by Emergent BioSolutions. In addition to today's press release, there is a series of slides accompanying the webcast available to all webcast participants.

Turning to slides 3 and 4, during today's call, Emergent may make projections and other forward-looking statements related to their business, future events, their prospects or future performance. These forward-looking statements are based on their current intentions, beliefs, and expectations regarding future events.

Any forward-looking statement speaks only as of the date of this conference call, and except as required by law, Emergent does not undertake to update any forward-looking statement to reflect new information, events or circumstances. Investors should consider this cautionary statement, as well as the risk factors identified in Emergent

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot